scholarly article | Q13442814 |
P356 | DOI | 10.14694/EDBOOK_AM.2014.34.215 |
P698 | PubMed publication ID | 24857079 |
P50 | author | Norbert Graf | Q39739734 |
Jeffrey S Dome | Q90449457 | ||
P2093 | author name string | Elizabeth J. Perlman | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nephroblastoma | Q756289 |
P304 | page(s) | 215-23 | |
P577 | publication date | 2014-01-01 | |
P1433 | published in | American Society of Clinical Oncology educational book / ASCO | Q26842316 |
P1476 | title | Risk stratification for wilms tumor: current approach and future directions |
Q28083988 | Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration |
Q38843141 | Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group |
Q92866879 | Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report |
Q61847867 | Botryoid Wilms tumor: a non-existent “entity” causing diagnostic and staging difficulties |
Q51739895 | Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors. |
Q90643339 | Development and validation of a nomogram for predicting cancer-specific survival in patients with Wilms' tumor |
Q58785977 | Educational Case: Wilms Tumor |
Q55402955 | Evaluation of renal tumors in children. |
Q38734260 | Factors possibly affecting prognosis in children with Wilms' tumor diagnosed before 24 months of age: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Wilms Tumor Working Group. |
Q36052678 | Genetic and chromosomal alterations in Kenyan Wilms Tumor |
Q37146691 | Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review |
Q55262812 | Germline mutations and somatic inactivation of TRIM28 in Wilms tumour. |
Q91729017 | Less may be more for stage I epithelial Wilms tumors |
Q90041553 | Loss of Heterozygosity at Chromosome 16q Is a Negative Prognostic Factor in Korean Pediatric Patients with Favorable Histology Wilms Tumor: A Report of the Korean Pediatric Hematology Oncology Group (K-PHOG) |
Q42371655 | Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms' tumor: a meta-analysis. |
Q59137136 | Lymph node imaging of pediatric renal and suprarenal malignancies |
Q37706888 | Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients |
Q47797328 | Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. |
Q30381395 | Peptide spectra in Wilms tumor that associate with adverse outcomes |
Q92219613 | Prognostic Factors and Nomograms to Predict Overall and Cancer-Specific Survival for Children with Wilms' Tumor |
Q50693805 | Prospective analysis of long-term renal function in survivors of childhood Wilms tumor. |
Q89365159 | Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database |
Q38630842 | Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group |
Q95852637 | Results of treatment for patients with multicentric or bilaterally predisposed unilateral Wilms tumor (AREN0534): A report from the Children's Oncology Group |
Q38972223 | Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group. |
Q48570161 | Surgical concepts in the treatment of Wilms tumor: An update |
Q47141863 | TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia |
Q38815578 | The Evolving Role of Minimally Invasive Surgery in Pediatric and Adolescent Urologic Oncology |
Q42995400 | The IGF signalling pathway in Wilms tumours--a report from the ENCCA Renal Tumours Biology-driven drug development workshop |
Q57476574 | The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol |
Q91297749 | The genetic changes of Wilms tumour |
Q33552390 | The prognostic significance of hypertension at diagnosis in children with wilms tumor |
Q53657080 | Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG). |
Q35622321 | Tumor size and prognosis in patients with Wilms tumor |
Q49846900 | Two rare cases of abdominal tumor in children: Answers |
Q54336619 | Whole-tumor apparent diffusion coefficient measurements in nephroblastoma: Can it identify blastemal predominance? |
Q47137911 | Wilms Tumor Treatment Outcomes: Perspectives From a Low-Income Setting |
Search more.